痛风急性和慢性期分子机制研究进展
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Progress in Molecular Mechanisms of Acute and Chronic Gout
  • 作者:胡伟琼 ; 程虹 ; 魏荣锐 ; 钟国跃 ; 艾永强 ; 王得运 ; 朱继孝
  • 英文作者:HU Weiqiong;CHENG Hongyu;WEI Rongrui;ZHONG Guoyue;AI Yongqiang;WANG Deyun;ZHU Jixiao;Research Center of Chinese Herbal Medicine and Ethnic Medicine, Jiangxi University of Traditional ChineseMedicine;School of Humanities,Jiangxi University of Traditional ChineseMedicine;
  • 关键词:痛风 ; 急性期 ; 慢性期 ; 分子机制 ; 中药治疗
  • 英文关键词:Gout;;acute phase;;chronic phase;;molecular mechanism;;Chinese medicine treatment
  • 中文刊名:ZYXY
  • 英文刊名:Traditional Chinese Drug Research & Clinical Pharmacology
  • 机构:江西中医药大学中药资源与民族药研究中心;江西中医药大学人文学院;
  • 出版日期:2019-03-25
  • 出版单位:中药新药与临床药理
  • 年:2019
  • 期:v.30;No.156
  • 基金:国家自然科学基金项目(81660702);; 江西省卫计委中医药科技计划项目(2016A030)
  • 语种:中文;
  • 页:ZYXY201903022
  • 页数:6
  • CN:03
  • ISSN:44-1308/R
  • 分类号:115-120
摘要
痛风是嘌呤代谢紊乱的代谢性疾病,其发病率呈明显升高趋势发展。痛风分为无症状的高尿酸血症时期、急性痛风关节炎时期、间歇期、慢性痛风关节炎时期。痛风急性期以激活TOLL样受体(TLRs)、NOD样受体蛋白3(NLRP3)、P2X7受体(P2X7R)为主;痛风慢性期以刺激中性粒细胞胞外诱捕网(NETs)生成、内质网应激,激活核转录因子-κB受体(RANK)为主。作者对痛风急性、慢性期分子机制进行综述,为开展中医药治疗痛风的药理机制研究,研发治疗痛风中药提供参考。
        Gout is a metabolic disease with metabolic disorders of purine,and its incidence is obviously increasing.Course of gout is divided into asymptomatic period of hyperuricemia,acute gout arthritis,intermittent,and chronicgout arthritis. The acute phase of gout activates TOLL-like receptors(TLRs), NOD-like receptor protein 3(NLRP3), and P2X7 receptor(P2X7R); the chronic phase of gout stimulates neutrophil extracellular trappingnetworks(NETs) generation,endoplasmic reticulum stress,activation of nuclear transcription factor-κB receptor(RANK). This article reviews the molecular mechanisms of acute and chronic gout,and provides references for theresearch of pharmacological mechanisms of gout and the development of traditional Chinese medicine for treating gout.
引文
[1]SHEKELLE P G,NEWBERRY S J,FITZGERALD J D,et al.Management of gout:a systematic review in support of an American college of physicians clinical practice guideline[J].Annals of Internal Medicine,2017,166(1):37-51.
    [2]MITCHELL S,MANOUNAH L,LIEDGENS H,et al.The effect of serum uric acid levels on tophus status and flares in patients with gout:a systematic review[C]//European Congress of Rheumatology,2017:1369-1370.
    [3]GUO J,ZHAO S,RHEUMATOLOGY D O.Necessity of health management in the treat-to-target therapy of hyperuricemia and gout[J].Journal of New Medicine,2017,48(6):365-368.
    [4]CHEN Y,TANG Z,HUANG Z,et al.The prevalence of gout in mainland China from 2000 to 2016:a systematic review and metaanalysis[J].Journal of Public Health,2017,25(5):521-529.
    [5]那莎,段陈方圆,王璐,等.牛膝总皂苷对大鼠急性痛风性关节炎的防治作用及机制研究[J].中国临床药理学与治疗学,2017,22(9):966-971.
    [6]李钟,韩彬,黄惠珠,等.虎杖-桂枝药对配伍对急性痛风性关节炎大鼠TLR4/MyD88信号转导通路的影响[J].广州中医药大学学报,2015,32(6):1040-1046.
    [7]HALL C J,SANDERSON L E,LAWRENCE L M,et al.Blocking fatty acid-fueled m ROS production within macrophages alleviates acute gouty inflammation[J].Journal of Clinical Investigation,2018,128(5):1752-1771.
    [8]YU K H,CHEN D Y,CHEN J H,et al.Management of gout and hyperuricemia:Multidisciplinary consensus in Taiwan[J].International Journal of Rheumatic Diseases,2018,21(4):772-787.
    [9]SNODGRASS R G,HUANG S,CHOI I W,et al.Inflammasomemediated secretion of IL-1βin human monocytes through TLR2activation;modulation by dietary fatty acids[J].Journal of Immunology,2013,191(8):4337-4347.
    [10]TANG A C,RAHAVI S M,FUNG S Y,et al.Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1βproduction[J].Cell Death&Disease,2018,9(2):162-174.
    [11]LIU S,JIA H,HOU S,et al.Recombinant Mtb9.8 of Mycobacterium bovis stimulates TNF-αand IL-1βsecretion by RAW264.7macrophages through activation of NF-κB pathway via TLR2[J].Scientific Reports,2018,8(1):1928-1938.
    [12]HE M,ICHINOSE T,SONG Y,et al.Desert dust induces TLRsignaling to trigger Th2-dominant lung allergic inflammation via a MyD88-dependent signaling pathway[J].Toxicology&Applied Pharmacology,2016,296:61-72.
    [13]SRIVASTAVA N,SHELLY A,KUMAR M,et al.Aeromonas hydrophila utilizes TLR4 topology for synchronous activation of MyD88 and TRIF to orchestrate anti-inflammatory responses in zebrafish[J].Cell Death Discov,2017,3:17067-17075.
    [14]SUN Y,TONG P,LI X J,et al.Study on mechanism of influence of toll-like receptor 4/NF-κB signal transduction pathway in treatment of acute gouty arthritis using meridian-guiding herb[J].Chinese Archives of Traditional Chinese Medicine,2015,33(9):2195-2200.
    [15]QING Y F,ZHANG Q B,ZHOU J G,et al.Changes in toll-like receptor(TLR)4-NF-κB-IL-1βsignaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis[J].Rheumatology International,2014,34(2):213-220.
    [16]MYLONA E E,MOUKTAROUDI M,CRISAN T O,et al.Enhanced interleukin-1βproduction of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals[J].Arthritis Research&Therapy,2012,14(4):158-167.
    [17]LIU L,XUE Y,ZHU Y,et al.Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout[J].Arthritis Research&Therapy,2016,18(1):268-281.
    [18]LIU J,QIAN C,CAO X.Post-translational modification control of innate immunity[J].Immunity,2016,45(1):15-30.
    [19]MóTYáN J A,BAGOSSI P,BENK S,et al.A molecular model of the full-length human NOD-like receptor family CARD domain containing 5(NLRC5)protein[J].Bmc Bioinformatics,2013,14(1):275-285.
    [20]SUE F,KOGA K,TAGUCHI A,et al.Effects of omega-3 fatty acids on Nod-like receptor 3(NLRP3)inflammasome in decidualmacrophages[J].Journal of Reproductive Immunology,2016,115:33-33.
    [21]HO S C,CHANG Y H.Comparison of inhibitory capacities of 6-,8-and 10-gingerols/shogaols on the canonical NLRP3 inflammasomemediated IL-1βSecretion[J].Molecules,2018,23(2):466-477.
    [22]CAO W,YAN Z,SU S,et al.Chlamydial plasmid-encoded protein pORF5 induces production of IL-1βand IL-18 via NALP3inflammasome activation and p38 MAPK pathway[J].Int J Clin Exp Med,2015,8(11):20368-20379.
    [23]LIU H J,PAN X X,LIU B Q,et al.Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression[J].Journal of Neuroinflammation,2017,14(1):74-74.
    [24]SCHORN C,FREY B,LAUBER K,et al.Sodium overload and water influx activate the NALP3 inflammasome[J].Journal of Biological Chemistry,2011,286(1):35-41.
    [25]ABAIS J M,XIA M,ZHANG Y,et al.Redox regulation of NLRP3 inflammasomes:ROS as trigger or effector[J].Antioxidants&Redox Signaling,2015,22(13):1111-1129.
    [26]林椠.痛风康宁方对急性痛风性关节炎大鼠血清症因子及氧化应激的影响[D].唐山:华北理工大学,2018.
    [27]ANDRéS M,FRANCéS R,PASCUAL E.Uric acid enhances monosodium urate induced pro-inflammatory response in gouty patients:A basic and translational research study[J].Annals of the Rheumaic Diseases,2015,74(Suppl 2):777-778.
    [28]GREEN J P,SOUILHOL C,XANTHIS I,et al.Atheroprone flow activates inflammation via endothelial ATP-dependent P2X7-p38signalling[J].Cardiovascular Research,2017,114(2):324-335.
    [29]GONG Q Y,CHEN Y.Correlation between P2X7 receptor gene polymorphisms and gout[J].Rheumatology International,2015,35(8):1307-1310.
    [30]RABADI M M,KIM M,LI H,et al.ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI[J].Am J Physiol Renal Physiol,2018,314(2):293-305.
    [31]GIULIANI A L,SARTI A C,FALZONI S,et al.The P2X7receptor-interleukin-1 liaison[J].Front Pharmacol,2017,8:123-132.
    [32]STOKES L,FULLER S J,SLUYTER R,et al.Two haplotypes of the P2X(7)receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion[J].Faseb Journal,2010,24(8):2916-2927.
    [33]DE T C,BARBERà-CREMADES M,GóMEZ A I,et al.Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process[J].Sci Rep,2016,6:22586-22596.
    [34]MARTINON F,PéTRILLIV V,MAYOR A,et al.Gout-associated uric acid crystals activate the NALP3 inflammasome[J].Nature,2006,440:237-247.
    [35]MARTINON F,PéTRILLI V,MAYOR A,et al.Gout-associated uric acid crystals activate the NALP3 inflammasome[J].Nature,2006,440:237-241.
    [36]KUMAGAI Y,AKIRA S.Role of TLR-dependent and independent pathways in autoimmunity[J].Nihon Rinsho Japanese Journal of Clinical Medicine,2009,67(3):487-493.
    [37]MITROULIS I,KAMBAS K,CHRYSANTHOPOULOU A,et al.Neutrophil extracellular trap formation is associated with IL-1βand autophagy-related signaling in gout[J].Plos One,2011,6(12):e29318.
    [38]SCHAUER C,JANKO C,MUNOZ L E,et al.Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines[J].Nature Medicine,2014,20(5):511-517.
    [39]SCHETT G,SCHAUER C,HOFFMANN M,et al.Review:Why does the gout attack stop?A roadmap for the immune pathogenesis of gout[J].Rmd Open,2015,1(Suppl 1):e000046.
    [40]PANG L,HAYES C P,BUAC K,et al.Pseudogout-associated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps[J].Journal of Immunology,2013,190(12):6488-6500.
    [41]NAKAMURA S,MIKI H,KIDO S,et al.Activating transcription factor 4,an ER stress mediator,is required for,but excessive ERstress suppresses osteoblastogenesis by bortezomib[J].International Journal of Hematology,2013,98(1):66-73.
    [42]LEE H Y,CHAE H J,PARK S Y,et al.Porcine placenta hydrolysates enhance osteoblast differentiation through their antioxidant activity and effects on ER stress[J].Bmc Complementary&Alternative Medicine,2016,16(1):291-300.
    [43]TANAKA K,KAJI H,YAMAGUCHI T,et al.Involvement of the osteoinductive factors,Tmem119 and BMP-2,and the ER stress response PERK-eIF2α-ATF4 pathway in the commitment of myoblastic into osteoblastic cells[J].Calcif Tissue Int,2014,94(4):454-464.
    [44]CAI X,BAO L,DAI X,et al.Quercetin protects RAW264.7 macrophages from glucosamine-induced apoptosis and lipid accumulation via the endoplasmic reticulum stress pathway[J].Molecular Medicine Reports,2015,12(5):7545-7553.
    [45]LEE H E,YANG G,KIM N D,et al.Targeting ASC in NLRP3inflammasome by caffeic acid phenethyl ester:a novel strategy to treat acute gout[J].Scientific Reports,2016,6:38622-38632.
    [46]Dalbeth N,Chhana A.Mechanisms of bone erosion in chronic gout:lessons learned from other erosive arthropathies[J].Current Rheumatology Reviews,2011,7(2):152-161.
    [47]LEE S J,NAM K I,JIN H M,et al.Bone destruction by receptor activator of nuclear factorκB ligand-expressing T cells in chronic gouty arthritis[J].Arthritis Research&Therapy,2011,13(5):164-175.
    [48]DALBETH N,SMITH T,NICOLSON B,et al.Enhanced osteoclastogenesis in patients with tophaceous gout:urate crystals promote osteoclast development through interactions with stromal cells[J].Arthritis&Rheumatology,2008,58(6):1854-1865.
    [49]HARRE U,DERER A,SCHORN C,et al.T cells as key players for bone destruction in gouty arthritis[J].Arthritis Research&Therapy,2011,13(6):135-136.
    [50]SCHLESINGER N,THIELE R G.The pathogenesis of bone erosions in gouty arthritis[J].Annals of the Rheumatic Diseases,2010,69(11):1907-1912.
    [51]WANG X T,LI P,XU T S,et al.Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis[J].Cellular and Molecular Biology,2016,62(12):44-50.
    [52]HOU P Y,MI C,HE Y,et al.Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice[J].Fitoterapia,2015,105:43-48.
    [53]HONG S S,SEO K,LIM S C,et al.Interaction characteristics of flavonoids with human organic anion transporter 1(h OAT1)and 3(hOAT3)[J].Pharmacol Res,2007,56(6):468-473.
    [54]RUIZ-MIYAZAWA K W,STAURENGO-FERRARI L,MIZOKA-MI S S,et al.Quercetin inhibits gout arthritis in mice:induction of an opioid-dependent regulation of inflammasome[J].Inflammopharmacology,2017,25:555-570
    [55]LUO F,MEI Y.Effects of procyanidins on TLR4/NF-κB signaling pathway in rats with acute gouty arthritis[J].Chinese Journal of Clinical Pharmacology&Therapeutics,2018,23(1):41-46.
    [56]LIU H J,PAN X X,LIU B Q,et al.Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression[J].Journal of Neuroinflammation,2017,14(1):74.
    [57]ZHOU Q,LIU S,DONGHUA Y,et al.Therapeutic effect of total saponins from dioscorea nipponica makino on gouty arthritis based on the NF-κB signal pathway:an in vitro study[J].Pharmacognosy Magazine,2016,12(47):235-240.
    [58]ZHOU Q,LIN F F,LIU S M,et al.Influence of the total saponin fraction from dioscorea nipponica makino on TLR2/4-IL1R receptor singnal pathway in rats of gouty arthritis[J].Journal of Ethnopharmacology,2017,206:274-282.
    [59]WANG P,REN D,CHEN Y,et al.Effect of sodium alginate addition to resveratrol on acute gouty arthritis[J].Cell Physiol Biochem,2015,36(1):201-207.
    [60]HU Q H,JIAO R Q,WANG X,et al.Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice[J].J Ethnopharmacol,2010,128(3):685-692.
    [61]LIU Y F,TU S H,CHEN Z,et al.Effects of modified simiao decoction on IL-1βand TNFαsecretion in monocytic THP-1 cells with monosodium urate crystals-induced inflammation[J].Evid Based Complement Alternat Med,2014,3:406816.
    [62]袁晓,范永升,谢冠群,等.基于“TLR4/NF-κB”信号通路研究“加味四妙丸”治急性痛风性关节炎大鼠的作用机制[J].浙江中医药大学学报,2017,41(1):17-24.
    [63]ZHANG J Y,WU S N,WANG J,et al.Regulatory effect of tongfengtai granules on key genes in TLRs/NF-κB signaling pathway[J].World Journal of Integrated Traditional&Western Medicine,2016,11(6):750-754.
    [64]尤元梅,袁松,万毅痛风康对痛风性关节炎大鼠TLR4/NF-κB通路的影响[J].包头医学院学报,2018,34(1):95-98.
    [65]李欣,柴晶美,杨阿龙,等.上中下通用痛风汤对痛风性关节炎模型TLR4信号通路的影响[J].长春中医药大学学报,2018,34(1):23-25.
    [66]MENG H C,LEE H L,TU L.The culprit of gout:triggering factors and formation of monosodium urate monohydrate[J].Crystengcomm,2015,18(2):290-297.